Skip to main content
. 2023 Mar 2;9:e42350. doi: 10.2196/42350

Table 5.

Annual outpatient expense compared by age at entry.a

Age at entry (years) Study groups

Cancer groups (ICD-9-CMb) Comparison group

Hematologic cancer (200-208) (n=3934) P valuec Brain cancer (191-192) (n=2241) P valuec Benign brain tumor (225) (n=7825) P valuec Non-CNSd solid tumor (140-190; 193-199) (n=19,105) P valuec No cancer individuals (n=64,754) P valuec
0-2 257.74 (166.83-408.19) Reference 525.27 (228.69-1847.69) Reference 329.36 (197.63-621.16) Reference 245.14 (157.84-393.75) Reference 212.38 (136.58-329.15) Reference
3-5 251.85 (133.05-323.90) <.001 415.33 (204.98-1397.82) .33 272.84 (151.28-550.89) <.001 191.24 (118.96-305.10) <.001 162.35 (102.46-251.89) <.001
6-11 202.41 (126.32-330.68) <.001 457.92 (197.78-1303.71) .25 231.84 (140.18-419.25) <.001 186.55 (108.48-306.03) <.001 152.34 (92.1-239.84) <.001
12-17 245.39 (142.83-386.15) .01 481.73 (240.08-1364.01) .53 286.93 (165.13-507.47) <.001 238.28 (138.16-399.03) <.001 182.10 (103.66-296.48) <.001

aData represent the median expense in US $ per person per year (IQR).

bICD-9-CM: International Classification of Diseases, Ninth Revision, Clinical Modification.

cCompared with the age of 0-2 years in each group.

dCNS: central nervous system.